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ABSTRACT 
 
 
Purpose: This thesis aims to illustrate the Italian validation of a scale measuring self-
efficacy in diabetes management (Diabetes Management Self-Efficacy Scale, DMSES) in 
adults with diabetes.  
 
Methods: Two cross-sectional studies were conducted with patients attending the 
Diabetology Unit of San Marino and Bologna Hospitals. In study I, patients completed a 
socio-demographic and clinical data form, the Italian version of the DMSES (IT-
DMSES) and 3 self-report questionnaires measuring diabetes distress (PAID-5), 
psychological well-being (WHO-5) and depression (PHQ-9). Psychometric testing 
included construct validity (Principal Component Analysis), internal consistency 
(Cronbach’s α coefficient) and convergent/discriminant validity (Spearman’s correlation 
coefficient). In study II, a network analysis of the IT-DMSES was conducted to 
investigate the differences in self-efficacy between type 1 and type 2 diabetes and 
between males and females. 
 
Results: Overall, 105 patients with type 1 diabetes and 306 with type 2 diabetes were 
recruited at the two study sites. The IT-DMSES proved to consist of two factors, 
including disease management and lifestyle management. The second factor showed a 
good convergent validity with the well-being index. Results from network analysis 
showed that disease management and lifestyle management are two spatially distinct but 
related clusters of items, consistent across types of diabetes and genders. The pattern of 
correlations among items proved to be significantly different between type 1 and 2 
diabetes. 
 
Conclusions: IT-DMSES can be used in research and clinical practice in people living 
with diabetes to assess self-efficacy.  In type 1 diabetes, educational interventions aimed 
at empowering patients in coping with their disease are likely to affect both disease 
management and lifestyle management. On the contrary, in type 2 diabetes, educational 
interventions targeted on disease management may have a limited effect on the adoption 
of healthy lifestyles and vice versa. 
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CHAPTER 1  
 
 
1. Introduction  
 
Diabetes mellitus is a chronic condition with a high prevalence. In 2017 the International 
Diabetes Federation estimated that about 425 million of people (8,8% of adults 20-79 
years) have diabetes (87-91%  type 2 and 7-12%  type 1) and that 4 million people die 
from diabetes or its complications  (IDF, 2017). 
In fact, diabetes is a major cause of blindness, kidney failure, heart attacks, stroke and 
lower-limb amputation (WHO, 2016). 
In 2016, in Italy over 3.2 million people have been diagnosed with diabetes (about 90% 
have type 2 and 9-10% type 1 diabetes), representing 5.3% of the Italian population 
(16.5% among people 65 years old and over) (Istituto Nazionale di Statistica, 2017). 
People with diabetes have to deal with multiple tasks in order to treat and regulate their 
disease, and especially to prevent chronic kidney disease, central nervous system 
complications, damage to the blood vessels of the eye. Blood sugar control, 
administration of insulin or taking oral hypoglycemic drugs and life styles concerning 
nutrition and physical exercise are examples of daily behaviors and activities that the 
patient needs to plan and carry out to manage their disease. Patients indicate that they 
consider managing self-care activities more difficult than the diagnosis of diabetes itself 
(Anderson, 1985). 
In fact, once the diagnosis is established, patients with diabetes are expected to follow a 
complex set of self-care activities to manage their disease on a daily basis. The American 
Association of Diabetes Educators (AADE) specifies seven self-care behaviors to 
promote healthy outcomes, including healthy eating, physical activity, monitoring 
indicators of diabetes control (such as blood glucose and glycosylated haemoglobin), 
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taking medication, problem solving and healthy coping (Coyle, Francis, & Chapman, 
2013). In order to support the person with diabetes in managing these self-care activities, 
the American Diabetes Association (ADA) and the AADE suggested to incorporate the 
diabetes self-management education and support in the healthcare models (Riddle et al., 
2018). These interventions should facilitate the knowledge and ability necessary for 
diabetes self-care and support  people with diabetes in implementing and sustaining the 
behaviors needed to manage their chronic condition (Beck et al., 2017).  
On this regard, the ADA recommends to providers that they should consider the burden 
of treatment and patient levels of confidence/self-efficacy for management behaviors 
(Young-Hyman, 2016). 
 
The concept of self-efficacy has been introduced in 1960 with Albert Bandura within the 
“social learning theory” and is defined as people’s beliefs in their capability to organize 
and execute the course of action required to deal with prospective situations (Bandura 
1997; 1998).  
It is concerned not only with the skills one has but with judgements of what one can do 
with whatever skills one possesses (Bandura & National Inst of Ment Health, 1986). 
According to the self-efficacy theory (Bandura, 1994; Bandura & National Inst of Ment 
Health, 1986), the expectations of personal mastery (efficacy expectations or self-
efficacy) and success (outcome expectations) determine whether an individual will 
engage in one particular behavior. 
Self-efficacy, or the belief that one can self-manage one’s own health, is an important 
goal of healthcare providers, particularly in chronic illness (Lenz, 2002). 
Being highly self-efficacious is a key factor in successful chronic disease self-
management (Devarajooh & Chinna, 2017).  
11 
 
For this reason, the ADA (Beck et al., 2017) recommends that self-efficacy should be 
measured to assess confidence in performing diabetes self-care activities. In fact, from a 
perspective of patient-centered psychosocial care in diabetes (Young-Hyman, 2016), 
targeting interventions according to patient’s self-efficacy has a key role to improve 
diabetes self-management (Beckerle & Lavin, 2013; Iannotti et al., 2006; King et al., 
2010; Nouwen, Urquhart Law, Hussain, McGovern, & Napier, 2009; Sarkar, Fisher, & 
Schillinger, 2006). 
A systematic review (Hamzah, 2013) identified 14 studies that conducted research in the 
context of measuring self-efficacy in type 2 diabetes management. The review concluded 
that the Diabetes Management Self-Efficacy Scale (DMSES) is the most widely used 
scale and also some countries such as Australia, UK and China had accepted the use of 
the scale as a best practiced model. The DMSES in comparison to the Diabetes 
Empowerment Scale (Anderson, 2000), which assesses psychosocial self-efficacy 
perceptions, is focused on functional diabetes management behaviours. Moreover, it is 
based on self-care activities the patients have to carry out in order to manage their 
diabetes and to prevent complications. For this reason, the main advantage of using the 
DMSES is the possibility to assess attitudes regarding lifestyle, foot care, weight control, 
medication adherence, ability to measure blood glucose levels when necessary and also 
the differences between managing higher and lower blood glucose levels.  
The original version of the instrument was developed in Dutch (Van der Bijl, 1999) and 
consisted of 20 items. Currently it has been validated in Greek, Korean, Chinese, Iranian, 
Turkish, Thai (Fappa et al., 2016; Lee et al., 2015; Vivienne et al., 2008; Noroozi et al., 
2014; Kara et al., 2006; Sangruangake et al., 2017) and in an Australian (McDowell et al., 
2005) population, demonstrating acceptable reliability and validity. Factor analysis in 
Greek, Korean and Chinese versions yielded four factors, five in the Iranian version and 
three in the Turkish version. A UK validation study reduced the DMSES to 15 items 
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(Sturt et al., 2010).  The DMSES UK (Sturt et al., 2010) was found to be negatively 
correlated with diabetes distress and glycated haemoglobin levels and one factor solution 
was found.  
 
Given the aims of study I, my interest moved than to analyse potential differences 
between type 1 and type 2 in the perceived confidence on diabetes self-management.  
In fact, it is unknown whether the self-efficacy constructs measured by this scale and the 
correlations between items differ between type 1 and type 2 diabetes or between genders. 
Understanding whether specific aspects of self-efficacy are more prominent or more 
strongly interlinked in different patient subgroups is relevant for the design of targeted 
psychoeducational interventions to promote effective self-care.   
In order to examine the empirical relationships among self-efficacy items in deeper detail, 
we used network analysis.  Network modeling is a novel way of representing 
psychological constructs as complex systems of interacting variables. The inspection of 
networks allows understanding the extent to which items belonging to the same construct 
are connected to each other and the strength of their mutual relationships. Although in the 
majority of applications the analysis was typically limited to investigating a network 
structure in a single population, recently the focus has shifted from single population 
studies to studies comparing network structures from different subpopulations (van 
Borkulo et al., 2015) and specific tests have been developed (van Borkulo et al., 2016) to 
examine whether the network structure is identical across subpopulations, whether 
specific correlations differ in strength between subpopulations and whether the overall 
connectivity is equal across subgroups.  
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It is well known that type 1 and type 2 diabetes have a different pathogenesis, age of 
onset, and require different therapeutic strategies for the glycemic control. Regarding 
gender, differences have been reported on disease management compliance with 
treatment and complications (Ballotari, Venturelli, Greci, Giorgi Rossi, & Manicardi, 
2017; Maiorino et al., 2018; McCollum, Hansen, Lu, & Sullivan, 2005). 
Given clinical knowledge and previous evidence, we hypothesized that patients with type 
1 and type 2 diabetes as well as males and females would feel differently capable of 
managing some aspects of their disease and applied network analysis to investigate  the 
structure of the self-efficacy network in type 1 and type 2 diabetes, and in males and 
females  stratified by type of diabetes.  
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CHAPTER 2 
 
 
2. Aims 
 
The aim of this thesis was to validate the Italian version of the DMSES and to explore 
whether specific aspects of self-efficacy are more strongly interlinked in different patient 
subgroups in order to design targeted psychoeducational interventions to promote 
effective self-care. 
 
Study I (Messina, Rucci et al. 2018) 
- To translate and adapt the English version of the scale to Italian and to evaluate the 
psychometric properties of the Italian version of DMSES (IT-DMSES) in type 2 
diabetes. 
 
Study II (Rucci, Messina et al. 2018) 
- To investigate the structure of IT-DMSES self-efficacy network in type 1 and type 2 
diabetes, and in males and females stratified by type of diabetes. 
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CHAPTER 3 
 
 
3. Methods 
 
3.1.1  Study I: Study design and population  
A cross-sectional study was conducted, 165 patients with type 2 diabetes attending the 
Endocrine-Metabolic Disease Unit Care of the Internal Medicine Department of San 
Marino State Hospital were recruited between October 2016 and February 2017. 
Inclusion criteria were: age >18-80 years; diagnosis of type 2 diabetes more than 6 
months. 
Exclusion criteria were: dementia; type 1 diabetes; gestational diabetes. 
The Ethics Committee of the Institute for Social Security (ISS) of San Marino approved 
the study procedures (registration number: 28/2016/CERS). All eligible patients provided 
a written informed consent after receiving an explanation of study procedures and aims 
and after having an opportunity to ask questions. 
16 
 
 
3.1.2 Adaptation of the DMSES: face and content validity 
The DMSES UK (Sturt et al., 2010) was chosen as the most appropriate version to 
translate to Italian because it had addressed the item redundancy in the original Dutch 
version of the instrument by reducing the number of items from 20 to 15. 
The DMSES was translated to Italian and then backtranslated to English by a bilingual 
English native speaker (Carlson, 2000; Erkut et al., 1999; De Vellis, 2003; Ahmed et al., 
2009). In order to improve the comprehensibility of the questionnaire for patients, items 
were reviewed by the research team, which included a public health professor, a 
statistician, a diabetologist and a psychologist. 
After language review (reported in deeper in the Papers section, study I) the version 
agreed with the team was administered to a pilot sample of 5 people with type 2 diabetes 
of the diabetes center using a cognitive interviewing methodology to assess the 
perception, usefulness and interpretation of each question of the measure (Erkut et al., 
1999; De Vellis, 2003).   
During completion, the 5 participants were asked to provide comments on items and the 
terminology, and comments were recorded in field notes. Results of the supervised pilot 
administration of the instrument indicated that patients had difficulties rating items 2, 3, 
4, 7, 11 and 12 (see table 1).  
The pilot group reported that the questionnaire was interesting and introduced all the 
issues related to diabetes; they stated also that completing the questionnaire in the 
presence of a doctor may prevent people from answering the questions honestly. 
Following this stage, items were revised by adding some examples and the Italian final 
version of DMSES (IT-DMSES) was agreed (see the additional file 1). 
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The 15 items of the Italian version of DMSES measure the individual’s efficacy 
expectations for engaging in diabetes self-management activities, for example, checking 
the blood sugar, following a healthy diet even when away from home. Items are scored 
on a 0–10 point numerical scale, with higher scores indicating higher self-efficacy levels 
(Fig. 1). The time of administration ranges from 10 to 20 minutes. 
 
3.1.3 Measures 
Patients completed a form including socio-demographic and information. Results from 
the scientific literature indicate that self-efficacy and diabetes self-management are 
associated with the psychological status of an individual (Sturt et al., 2015; Peyrot et al., 
2005). Therefore the convergent/discriminant validity of the IT-DMSES, was 
investigated by administering 3 questionnaires evaluating: diabetes distress (the Problem 
Areas in Diabetes-short form, PAID-5), well-being (the World Health Organization-5 
Well-Being Index, WHO-5) and depression (the Patient Health Questionnaire-9). 
The Problem Areas In Diabetes- Short form (PAID-5) 
This scale measures diabetes distress, patients’ specific worries and negative emotions 
related to their diabetes (McGuire et al., 2010; Polonksy et al., 1995). The instrument 
has been used in more than a hundred studies and in the DAWN MIND (monitoring 
individual needs in people with diabetes) (Snoek et al., 2011; Nicolucci et al., 2013) 
program across ten countries. The PAID-5 short form has been validated in Italian in 
the BENCH-D study (Nicolucci et al., 2014). 
It includes five items with responses on a five-point Likert scale, with a total score 
ranging from 0 to 100. A score ≥40 indicates elevated diabetes-related distress. 
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The World Health Organization-5 Well-Being Index (WHO-5) 
This scale, developed by the World Health Organization, assesses psychological well-
being, a core component of quality of life (Bech et al., 1996). The use of WHO-5 is 
recommended in international and some national treatment guidelines for diabetes 
after its worldwide use in the DAWN (Wroe, 2006). 
 It includes five items with responses on a six-point Likert scale, and the total score is 
rescaled to range from 0 to 100. A score ≤50 indicates poor psychological well-being, 
while a score ≤28 indicates likely depression. 
The Patient Health Questionnaire-9 
This questionnaire is used to screen patients for a possible diagnosis of major 
depression.  Scores range from 0 to 27, with cut-points of 5, 10, 15 and 20 indicating 
mild, moderate, moderately severe and severe levels of depressive symptoms 
(Kroenke et al., 2010; Mazzotti et al., 2003). 
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3.1.4 Statistical analysis: Principal Component Analysis, Internal Consistency,  
Convergent/Discriminant validity 
The sample size was set to a minimum of 150 in order to perform an exploratory 
principal component analysis, for which at least a ten-to-one ratio between patients and 
items is recommended (Nunnally, 1978).  
After descriptive analysis, principal component analysis (PCA) was performed to 
investigate DMSES construct validity. For this analysis, the very few missing items were 
replaced with mean values (28 missing items overall in 22 patients, corresponding to 
1%). The number of factors to be extracted was determined according to the scree-plot 
method (Cattell, 1983). Oblique rotation was performed using the promax method, to 
allow for the expected correlation between factors. 
Kaiser–Meyer–Olkin measure of sampling adequacy (KMO) and Bartlett’s test were 
calculated to evaluate the sample size adequacy. A KMO >0.8 indicates that the sampling 
is adequate. The p value of Bartlett’s test of sphericity (which tests the null hypothesis 
that the original correlation matrix is an identity matrix) should be significant and lower 
than 0.05. Factor scores were calculated using the regression method. 
Internal consistency was assessed using Cronbach’s α coefficient with cut-offs of .8 and 
.9 denoting good and excellent reliability. 
The convergent/discriminant validity of IT-DMSES vs. the PAID-5, the WHO-5 and the 
PHQ-9 was analysed by using Spearman’s correlation coefficient, because of the 
asymmetrical frequency distribution of item responses. High levels of self-efficacy are 
expected to be associated with low diabetes distress, a good psychological well-being and 
no depressive symptoms (Sturt et al., 2010; Sturt et al., 2006; Thoolen et al., 2006).  
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Decision tree with CRT method was used to classify patients into homogeneous 
subgroups of self-efficacy based on demographic and clinical characteristics, including 
gender, age, years of education and duration of illness. All analyses were performed 
using IBM SPSS, version 20. 
 
3.2.1 Study II: Study design and population 
In study II, the sample derived from that of the previous study I plus another group of 
patients recruited at the Diabetology Unit of Sant’Orsola-Malpighi Hospital Bologna 
(between 1 May 2017 and 31 October 2017) during this second cross-sectional study. 
Differently from study I, the sample included also people with type 1 diabetes. 
So that, inclusion criteria were: age between 18-80 years, clinical diagnosis of type 1 or 2 
diabetes for at least 6 months and willingness to sign informed consent¸ exclusion criteria 
were: clinical diagnosis of mild cognitive impairment/dementia and clinical diagnosis of 
gestational or iatrogenic diabetes.  
The study protocol was approved by the Ethics Committee of Sant’Orsola Hospital 
(currently Independent Ethics Committee of Center Emilia Area) (registration number: 
31/2017/U/Oss). 
All participants provided a written informed consent to participate after receiving a 
thorough explanation of the study procedures and having an opportunity to ask questions.  
Patients completed the validated version of the IT-DMSES. 
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3.2.2 Statistical analysis: Network analysis 
The 15 IT-DMSES items were used for the network analyses. A network is a graphical 
representation of the correlations between items. In this representation items are depicted 
as nodes and correlations as edges. Thicker and more saturated edges denote stronger 
correlations. Positive correlations are represented as green edges and negative 
correlations as red edges. The network display is based on an algorithm (Fruchterman & 
Reingold, 1991) that places strongly associated nodes at the center of the network and 
weakly associated nodes at the periphery.  
A network model including all possible correlations among items would require the 
estimation of a large number of parameters, including n threshold parameters for the 
nodes and n*(n-1)/2 parameters for the pairwise correlations between nodes. With 15 
items, this would amount to estimating 120 parameters. To deal with the problem of a 
relatively small dataset compared to the number of parameters, we used the ‘least 
absolute shrinkage and selection operator (LASSO)’ technique (Tibshirani, 1996), that 
leads many edge estimates to shrink to exactly zero and to drop out of the model. The 
LASSO returns a sparse, i.e. conservative, network model in which only a relatively 
small number of edges are used to explain the relationships among items. Because of this 
sparsity, the estimated models become more interpretable. The LASSO utilizes a tuning 
parameter to control the degree to which the removal of small correlations is applied. We 
selected this tuning parameter by minimizing the Extended Bayesian Information 
Criterion (Chen & Chen, 2014). To take into account the skewed distribution of items, a 
nonparanormal transformation was applied to the data (Liu, Lafferty, & Wasserman, 
2009).    
Then, to quantify the importance of each node in the network, we used the betweenness, 
centrality and degree indices. The betweenness denotes the number of times a specific 
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node acts as a bridge along the shortest path between two nodes, the closeness measures 
the number of direct and indirect links between one node and the others and the degree is 
the strength of links with the other nodes. These indices are normalized (mean=0 and 
standard deviation=1), so that an index with a value >1 indicates that it is >1 SD from the 
mean.  
The network analysis was conducted using the statistical software JASP version 0.8.6 
(JASP Team University of Amsterdam, 2018).  
The R-package NetworkComparisonTest was used to test (1) the invariant network 
structure, (2) the invariant edge strength, and (3) the invariant global strength between 
subgroups.
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CHAPTER 4 
 
 
4. Results 
 
4.1 Study I: Sample characteristics 
The study sample consists of 165 patients. Participants had a mean age of 65.2 (SD±9) 
years, 56.9% had been diagnosed for 1 to 15 years, 63% reported HbA1c levels 
>53mmol/mol, 66.7% were males, 79.7% were living with a spouse or partner and 71.5% 
were retired. Other clinical characteristics are reported in Table 2.  
PHQ-9 scores indicated that 62.7 % of patients had no depressive symptoms, 25.2 % 
mild, 10.8% moderate and 1.3% moderate to severe depressive symptoms. PAID-5 scores 
showed that 51.2 % of patients had elevated diabetes distress. WHO-5 scores indicated 
that 74.2% of patients had good psychological well-being, 17.6% had poor psychological 
well-being and 8.2% likely depression.   
 
4.1.1 Psychometric validation of the IT-DMSES 
Patients who completed the IT-DMSES were included in all the analyses (N=159). The 
KMO index was 0.86, indicating that the sample was adequate for factor analysis and 
Bartlett’s test of sphericity was significant, indicating strong correlation between 
variables. The PCA extracted three factors that accounted for 66.8% of the total variance. 
However, one of the factors included only two items and its eigenvalue was marginally 
higher than unity. Thus, a two-factor solution was selected that was more interpretable, 
and accounted for 56.6% of item variance. Factor 1 (including items: 1, 2, 3, 6, 14, 15) 
was labeled as “disease management” and factor 2 (including items: 4, 5, 7, 8, 9, 10, 11, 
12, 13) was labeled as “lifestyles management”. Table 3 shows the item loadings on the 
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two factors.  Two items had a cross-loading (item n. 6, factor 1=.415 factor 2=.322; item 
n.7, factor 1=.359 factor 2= .444). Disease Management had a good reliability (α=.849) 
and Lifestyle Management had an excellent reliability (α=.900).  
Patients who completed all scales were included in this analysis (N=151).  
A negative and weak correlation was found between DMSES factor 2 (Lifestyle 
management), PAID-5 (r=-0.258, p=<0.01) and PHQ-9 (r=-0.274, p=<0.01) and a 
positive one with WHO-5 (r=0.325, p<0.01) supporting convergent validity. This 
suggests that patients with higher self-efficacy had a higher well-being, lower distress and 
fewer depressive symptoms. 
DMSES factor 1 (Disease management) was uncorrelated with PAID-5 (r=-0.142, 
p=0.083), PHQ-9 (r=-0.145, p=0.076) and weekly correlated with WHO-5 (r=0.170, 
p=0.037) confirming discriminant validity. 
 
4.1.2 IT-DMSES Scoring Instructions 
Since IT-DMSES consists of two factors, two scores are necessary. Score ‘Disease 
Management’ is the weighted mean of items 1, 2, 3, 6, 14, 15. Score ‘Lifestyle 
Management’ is the weighted mean of items 4, 5, 7, 8, 9, 10, 11, 12, 13. Both of them 
range from 0-10: 0-3 denotes low levels of self-efficacy, 4-6 intermediate levels of self-
efficacy, 7-10 high levels of self-efficacy. Weights are provided in Table 4. 
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4.2 Study II: Sample characteristics 
Overall 411 patients were recruited, 246 in Bologna and 165 in San Marino. 
The Bologna sample included 105 patients with type 1 diabetes and 141 patients with 
type 2 diabetes, while the San Marino sample included 165 patients with type 2 diabetes. 
Patient characteristics by type of diabetes and by gender are reported in Tables 5 and 6.  
Patients with type 1 diabetes were younger, more frequently female, living with parents 
and employed than those with type 2 diabetes. They also had lower BMI, higher 
education and a longer history of disease. Hypertension, dyslipidemia, ischemic heart 
disease, kidney disease and eye damage were significantly more common in type 2 
diabetes. The treatment regimen in type 2 diabetes was oral hypoglycemic mono or pluri-
therapy in 42.2% of patients, combination of oral hypoglycemics and insulin in 43.8% 
and insulin alone in 10.5%. In type 1 diabetes, the large majority of patients were treated 
with insulin alone (93.3%) and 6.7% with insulin and oral hypoglycemics.  
In type 2 diabetes, comparisons between genders revealed that males were more likely to 
have ischemic heart disease, dyslipidemia and kidney, neurological and peripheral 
circulatory complications. However, females had more frequently thyroid diseases as 
comorbidity. In type 1 diabetes, the only gender differences included a poorer glycemic 
control and a higher frequency of thyroid disease in females. 
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4.2.1 Network analysis: Comparison between type 1 and type 2 diabetes  
This analysis was carried out in the overall sample, including 306 patients with type 2 
diabetes and 105 with type 1 diabetes. The network structure in type 2 and type 1 diabetes 
indicated that the IT-DMSES domains disease management and lifestyle management, 
colored respectively in red and blue, comprised two distinct clusters. However, the 
network structure, i.e. the pattern of correlations among items, proved to be significantly 
different between type 1 and 2 diabetes (M=0.66, p<0.001) (Fig. 2).  
The global strength test revealed a significantly stronger interconnection in type 2 
compared with type 1 diabetes (S=0.77, p=0.019). Notably, this result is accounted by the 
strong association in type 2 diabetes between items DM14 (take medications) and DM15 
(adjust medications), that are peripheral and almost disconnected from the rest of the 
network. Vice versa, in type 1 diabetes, self-efficacy in lifestyle management and disease 
management items are more densely but weakly interconnected with each other.  As 
expected, tests of specific edge strengths confirmed a significant difference (p<0.001) 
between type 2 and type 1 diabetes for the item pair DM14 (take medications)-DM15 
(adjust medications) (weight=0.790 in type 2, weight=0.280 in type 1) and identified 
additional differences for the pairs DM7 (adjust the eating plan when ill) -D10 (adjust 
diet when exercising) (weight=0.224 in type 1 and 0.023 in type 2), DM8 (regular diet) -
DM11 (eating diet when away from home) (weight 0.360 in type 1, weight=0.027 in type 
2), DM13 (adjust diet when distressed) -DM14 (take meds) (weight=0.149 in type 1, 
weight=0 in type 2). 
Concerning the centrality of self-efficacy items, in type 2 diabetes 3 items played a key 
role: DM2 (correct blood sugar when high) has the highest betweenness (connected 
directly more items with each other), DM7 (adjust diet when ill) had the highest 
closeness (direct and indirect connections with other items) and item DM8 (regular diet) 
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has the highest degree (stronger links with other items). In type 1 diabetes, item DM7 
(adjust diet when ill) has all the highest centrality indices.  
 
4.2.2 Network analysis: Gender differences in type 2 diabetes 
This analysis was carried out in the 192 males and 114 females with type 2 diabetes. The 
network structure was similar between genders (M=0.23, p=0.663) and the global 
strength was almost overlapping in males and females (S=0.02, p=0.953) (Fig. 3).  
Still, a visual inspection of the network showed some unique edges in males and females. 
While DM10 (adjust diet when exercising) was connected with DM13 (adjust diet when 
distressed) only in males DM6 (examine feet) was connected with DM3 (correct blood 
sugar when low), DM12 (healthy eating pattern when eating out) with DM13 (adjust diet 
when distressed) and DM8 (regular diet) with DM13 (adjust diet when distressed) only 
in females.  
 
4.2.3 Network analysis: Gender differences in type 1 diabetes 
This analysis included 52 females and 53 males with type 1 diabetes. The network 
structure and the global strength of the correlations proved to be invariant between 
genders (M=0.41, p=0.577 and S=0.05, p=0.937). However, the network showed some 
unique edges. In males, DM7 (adjust diet when ill) was connected with DM8 (regular 
diet) and DM1 (check blood sugar when necessary) with DM4 (choose correct foods); in 
females DM8 (regular diet) was connected with DM9 (take more exercise) 
(Supplementary Figure 1).  
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CHAPTER 5 
 
 
5. Discussion 
 
5.1 Study I 
The study indicates that IT-DMSES is not unidimensional, but consists of two main 
factors underlying the construct of self-efficacy: Disease Management and Lifestyle 
Management. Furthermore, the results showed that the DMSES factor 2 ’Lifestyle 
Management’  has a good convergent validity with the Well-Being index, suggesting that 
a higher perceived capability to manage diet and exercise is associated with higher 
subjective psychological well-being. This result is consistent with previous studies, in 
which higher self-efficacy was related to lower emotional distress (Sturt et al., 2010; 
Fisher et al., 2007). Factor 1 ‘Disease Management’ was uncorrelated with PAID-5, 
PHQ-9 and WHO-5, confirming that this factor measures a conceptually different 
construct from distress, depression and well-being. 
The identification of two dimensions of self-confidence in diabetes management has 
important implications on targeting personalised patient education interventions because 
it allows to know the activities in which patients are facing more difficulties. 
In addition, we found that self-efficacy is related to illness duration, gender and age.  
Higher levels of self-efficacy in lifestyle management were found in patients diagnosed 
for at least 1 year up to 15 years and aged >65 years and the poorest self-efficacy was 
found in males < 65 years. 
These results suggest that efforts to promote patient education to self-efficacy should be 
especially targeted to younger man, and to patients with a long-standing experience of 
disease.  
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The study has some limitations, one of which is the external validity, in fact the study 
sample attending the diabetes center included mostly elderly patients with comorbid 
diseases and complications. Therefore, our results cannot be generalized to all patients 
with type 2 diabetes.  
Another possible limitation is the social desirability bias, that is the tendency to over-
report good behaviors when answering questions. This may lead to an overestimation of 
patients’ ability to manage their diabetes.  
 
5.2 Study II 
This study is, to our knowledge, the first attempt to apply network analysis to investigate 
the relationships between diabetes self-efficacy items and to investigate the network 
structure and the strength of item relationships between type 1 and type 2 diabetes and 
between genders. 
The original result of the present study is the difference in the self-efficacy network 
structure between type 1 and type 2 diabetes. The high interconnections between items in 
type 1 diabetes indicated that, in general, patients’ perceived ability to address specific 
tasks to manage their illness is associated with their ability to control their lifestyle. Thus, 
educational interventions aimed at empowering patients in coping with their disease are 
likely to affect both these aspects.   
On the contrary, our findings indicate that in people with type 2 diabetes self-efficacy in 
taking and adjusting medications are two items strongly linked with each other but 
isolated and disconnected from the confidence in managing daily lifestyles. These 
findings suggest that an educational intervention targeted to support patients with type 2 
diabetes in managing their disease may have a limited effect on the adoption of healthy 
lifestyles and vice versa. Thus this study points to the need to set up psychoeducational 
interventions for type 2 diabetes in which the adoption of healthy lifestyles should be 
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given at least the same attention as the glycemic control and the treatment management. 
Because educational programs vary in the method of delivery, content, illness and 
behavior change theory, their quality and outcomes should be monitored rigorously. 
The IT-DMSES is a standardized validated tool that can be used to measure the 
psychosocial effects of educational programs in two ways. The first traditional way 
consists in analyzing changes in self-efficacy scores. 
The second innovative way, based on a network approach, consists in analyzing the item 
correlations before and after the program. Stronger links among items at the end of the 
educational program indicate that self-efficacy is improved and that confidence in 
managing specific tasks is connected to confidence in managing other tasks. On the 
contrary, looser and weak links would suggest that self-efficacy worsened. We argue that 
this alternative approach would offer a deeper insight into the self-efficacy aspects that 
change after the intervention and is consistent with self-efficacy theory which posits that 
confidence in self-care is not of a general nature but related to specific situations 
(Bandura & National Inst of Ment Health, 1986; van der Bijl & Shortridge-Baggett, 
2001). 
Our study has some limitations. This was a cross-sectional study measuring self-efficacy 
during a single study visit; therefore, we were unable to ascertain the persistence of self-
efficacy in diabetes management over time or the effects of educational intervention. 
The generalizability of these study findings above and beyond this patient population 
should be done with caution because our sample is not representative of patients with 
type 2 and type 1 diabetes in other settings, such as, for instance, primary care. Moreover, 
self-efficacy was assessed using a self-report measure. Patients’ perceived ability in 
diabetes management may be overestimated due to a social desirability bias since patients 
completed questionnaires in the presence of the researcher. Moreover, this self-report 
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instrument may have limitations for routine use in clinical settings where supported 
administration may be needed for elderly people or for people with vision problems.  
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CHAPTER 6 
 
 
6. Conclusion 
 
6.1 Study I 
IT-DMSES version has sound psychometric properties and measures two different 
dimensions of self-efficacy: disease and lifestyle management. Results support the 
validity and reliability of the instrument. IT-DMSES can be used in people living with 
type 2 diabetes to monitor diabetes self-management over time. 
 
6.2 Study II 
Network comparisons revealed differences between type 1 and type 2 diabetes 
concerning the centrality of specific self-efficacy aspects and the way in which these 
aspects are connected to each other. In particular, in type 1 diabetes, the ability to face 
non–regular self-management activities plays a central role because it is more 
interconnected with the other aspects of lifestyle and disease management than in type 2 
diabetes. Knowledge of these aspects can give useful directions to clinicians to target 
psychoeducational interventions to support patient in the self-management of their 
condition. No significant gender differences emerged in the network structure. Future 
perspectives include the use of the network approach to analyze the efficacy of self-
management educational programs in clinical trials and intervention studies. 
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TABLES AND FIGURES 
Table 1. Comments to items during pilot administration 
 
Items Comments 
2, 3 (1) people who do not have access to blood glucose 
monitors may just have the feeling of having high or 
low; 
(2) people guess whether their blood glucose is low 
or high based on expected or unknown symptoms; 
(3) people guess how to cope with these possible 
symptoms by changing food intake or insulin intake; 
(4) Never experienced a low glucose so they never 
had to correct it. 
4 “even if I am able to choose correct foods for my 
health, doesn’t mean that I do it because I am greedy” 
7 Someone did not understand the term ‘when I am ill’, 
was clarified using examples like “when you have a 
high temperature”. 
11, 12 It was necessary to explain the difference between 
following a healthy diet when eating outside the 
home (in a place that the person chooses) or eating 
out in places that the person does not choose (eg 
parties, birthdays where the person cannot choose 
what to eat).  
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TABLES AND FIGURES 
Table 2.  Demographic and clinical characteristics of study participants (N=165) and scales 
measuring self-efficacy, depression, diabetes distress and well-being.  
 
Characteristics N(%) or mean±SD 
Gender  
Males 110 (66.7%) 
Female 55   (33.3%) 
Age (years) (mean±SD) 65.2 ± 9 (range 35-80) 
Living situation  
With a spouse/partner  114 (79.7%) 
With parents 7 (4.9) 
Alone  22 (15.4%) 
Level of education 
Elementary school 
Middle school 
 
54 (33.1%) 
63 (38.7%) 
High school 34 (20.9%) 
College and above 12 (7.4%) 
No. of years since diagnosed with diabetes, no. (%)  
<1 year 
1-15 years 
>15 years 
11 (6.9%) 
91 (56.9%) 
58 (36.3%) 
Occupational status  
Employed 
Retired 
Unemployed 
40 (24.2%) 
118 (71.5%) 
2 (1.2%) 
Weight classification   
Normal weight 20 (12.1%) 
Overweight 51 (30.9%) 
Obese 94 (57.0%) 
HbA1c ̽ (mean±SD) 57.28±10.3 
HbA1c ≤53mmol/mol 61 (37%) 
HbA1c >53mmol/mol 104 (63%) 
Treatment regimen  
Diet/exercise only 10 (6.1%) 
Oral hypoglycemic agent 71 (43%) 
Insulin 11 (6.7%) 
Oral hypoglycemic agent + insulin 73 (44.2%) 
Co-morbidities  
Hypertension 126 (76.4%) 
Thyroid disease 45 (27.3%) 
Dyslipidemia 141 (85.5%) 
Ischemic heart disease 33 (20%) 
Complications  
Kidney disease 23 (13.9%) 
Eye damage 26 (15.8%) 
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Neurological disease 21 (12.7%) 
Foot complications 2 (1.2%) 
Peripheral circulatory complications 12 (7.3%) 
DMSES scores *  
Mean DMSES 1 factor score 8.53±1.63 
Mean DMSES 2 factor score 6.83±1.76 
PHQ-9 score†  
No depression 
Mild depression 
99 (62.7%) 
40 (25.2%) 
Moderate depression 17 (10.8%) 
Moderately severe depression 2 (1.3%) 
Mean PAID-5 score ‡ 39.32 ± 27.14 
Cut-off ≥40 (elevated diabetes distress) 83 (51.2%) 
Mean WHO-5 score § 63.43 ± 21.21 
Good psychological well-being 118 (74.2%) 
Poor psychological  well-being 
Likely depression 
28 (17.6%) 
13 (8.2%) 
 
*HbA1c values: generic target, not modified on patient characteristics. Missing values: 22 living situation; 2 
level of education; 5 n. of years since diagnosed with diabetes; 5 occupational status;  
 
Abbreviations: DMSES, Diabetes Management Self-Efficacy Scale; PHQ-9, Patient Health Questionnaire; 
PAID-5, the Problem Areas in Diabetes-Short Form; WHO-5, Well-Being Index.  
* 6 missing values; † 7 missing values; ‡ 3 missing values; § 6 missing values. 
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TABLES AND FIGURES 
 
Table 3. Factor loadings of the two factors extracted using principal component analysis with 
promax rotation. 
 
 
 
Factor 1 
Disease 
Management 
 
Factor 2 
Lifestyle 
Management 
 
DM1- Check my blood sugar where necessary .747  
DM2 - Correct my blood sugar when the sugar level is too 
high 
.731  
DM3 - Correct my blood sugar when the blood  
sugar level is too low 
.789  
DM4 - Choose the correct foods  .714 
DM5 - Keep my weight under control  .732 
DM6 - Examine my feet for cuts .415 .322 
DM7 - Adjust my eating plan when ill .359 .444 
DM8 - Follow a healthy eating pattern most of the  
time 
 .826 
DM9 - Take more exercise if the doctor advises me to  .753 
 DM10 - When taking more exercise I am able to  
adjust my eating plan 
 .573 
DM11 - Follow a healthy eating pattern when I am  
away from home 
 .865 
DM12 - Follow a healthy eating pattern when I am   
eating out or at a party 
 .844 
DM13 - Adjust my eating plan when I am feeling stressed 
or anxious 
 .638 
DM14 - Take my medication as prescribed .814  
DM15 - Adjust my medication when I am ill .870  
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Table 4. Weights of the all items for the IT-DMSES scoring. 
 
 
 
  
Components 
Lifestyle Disease 
DM1 -.006 .211 
DM2 .024 .206 
DM3 .006 .222 
DM4 .146 .025 
DM5 .151 -.021 
DM6 .064 .116 
DM7 .090 .099 
DM8 .170 -.004 
DM9 .155 -.019 
DM10 .117 .046 
DM11 .179 -.045 
DM12 .174 -.047 
DM13 .131 .035 
DM14 -.031 .230 
DM15 -.040 .246 
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Table 5. Socio-demographic and clinical characteristics of study participants (N=411). 
 
† t-test;  ^ chi-square 
 
 type 1  
(n=105) 
type 2 
(n=306) 
Comparison between type 1 
and 2 diabetes 
Test, p 
Female (%) 49.5 37.2 4.89 (0.027)^ 
Age (mean ± SD) 45.1±17.4 65.1±9.5 -14.80 (<0.001)† 
Employed (%) 62.9 26.9 43.55 (<0.001)^ 
BMI (mean ± SD) 24.4±3.7 30.3±5.6 -9.78 (<0.001)† 
HbA1c mmol/mol (mean ± 
SD) 
59.1±10.6 58.6±13.7 0.36 (0.720)† 
HbA1c % (mean ± SD) 7.6±1.0 7.5±1.2 0.35 (0.723)† 
Education (%)   54.70 (<0.001)^ 
Elementary school 7.6 26.3  
Middle school 14.3 36.2  
High school 46.7 26.3  
College and above 31.4 11.2  
Duration of diabetes 
diagnosis (%) 
  25.08 (<0.001)^ 
<1 year 1.9 4.6  
1-15 years 28.6 54.1  
>15 years 69.5 41.2  
Living condition (%)   24.68 (<0.001)^ 
Alone 17.1 14.7  
With a spouse/partner 58.1 70.3  
With parents 20.9 5.6  
Other/unknown 3.8 9.5  
Treatment regimen (%)    
Diet/exercise only 0.0 3.6 3.88 (0.049)^ 
Oral hypoglycemic agent 0.0 42.2 64.51 (<0.001)^ 
Insulin 93.3 10.5 248.29 (<0.001)^ 
Oral hypoglycemic agent + 
insulin 
6.7 43.8 47.81 (<0.001)^ 
Co-morbidities (%)    
Thyroid disease 14.3 17.5 0.58 (0.447)^ 
Hypertension 18.1 71.0 89.54 (<0.001)^ 
Dyslipidemia 11.4 58.5 69.62 (<0.001)^ 
Ischemic heart disease 9.5 25.7 12.03 (0.001)^ 
Complications (%)    
Kidney disease 4.8 14.5 6.98 (0.008)^ 
Eye damage 40.0 23.4 10.81 (0.001)^ 
Neurological disease 14.3 13.2 0.08 (0.770)^ 
Foot complications 7.6 3.9 5.26 (0.072)^ 
Peripheral circulatory 
complications 
3.8 6.6 1.07 (0.301)^ 
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Table 6. Gender differences in type 1 and type 2 diabetes (n=411 patients).  
 
^ Chi-square test; † T-test 
 Males 
Type 2 
Diabetes 
(n=192) 
Females 
Type 2 
Diabetes 
(n=114) 
Comparison 
Test, p 
Males Type 
1 Diabetes 
(n=53) 
Females 
Type 1 
Diabetes 
(n=52) 
Comparison 
Test, p 
Age (mean ± 
SD) 
65.6±9.2 64.4±9.9 1.13 (0.259)† 43.7±18.0 46.5±16.8 -0.82 (0.411)† 
Employed (%) 25.9 28.6 0.25 (0.617)^ 67.9 57.7 1.18 (0.278)^ 
BMI (mean ± 
SD) 
30.3±5.2 30.4±6.7 -0.21(0.833)† 25.0±3.3 23.8±4.0 1.68 (0.096)† 
HbA1c 
mmol/mol 
(mean ± SD) 
58.0±12.5 59.6±15.6 -1.02 (0.309)† 55.5±10.2 62.7±9.7 -3.69(<0.001)† 
HbA1c % 
(mean ± SD) 
7.4±1.1 7.6±1.4 -1.01 (0.314)† 7.2±0.9 7.9±0.9 -3.66 
(<0.001)† 
Education (%)   3.59 (0.309)^   3.58 (0.311)^ 
Elementary 
school 
24.1 30.1  5.7 9.6  
Middle school 35.1 38.0  17.0 11.5  
High school 29.8 20.3  52.8 40.4  
College and 
above 
11.0 11.5  24.5 38.5  
Duration of 
diabetes (%) 
  0.90 (0.635)^   2.00 (0.367)^ 
<1 year 5.3 3.5  3.8 0.0  
1-15 years 55.2 52.6  28.3 28.8  
>15 years 39.6 43.9  67.9 71.1  
Living condition 
(%) 
  0.83 (0.842)^   1.90 (0.594)^ 
Alone 14.6 14.9  20.7 13.5  
With a 
spouse/partner 
71.3 68.4  56.6 59.6  
With parents 5.7 5.3  20.7 21.1  
Other 8.3 11.4  1.9 5.8  
Treatment 
regimen (%) 
      
Diet/exercise  5.2 0.9 3.87 (0.050)^ 0.0 0.0  
Oral hypo. 38.5 48.2 2.76 (0.100)^ 0.0 0.0  
Oral hypo. + 
Insulin 
42.2 46.5 0.54 (0.463)^ 5.7 7.7 0.17 (0.676)^ 
Insulin 14.1 4.4 7.15 (0.007)^ 94.3 92.3 0.17 (0.676)^ 
Co-morbidities 
(%) 
      
Thyroid disease 11.6 27.2 11.92(0.001)^ 5.7 23.1 6.50 (0.011)^ 
Hypertension 72.1 69.3 0.27 (0.601)^ 20.7 15.4 0.51 (0.475)^ 
Dyslipidemia 64.1 49.1 6.57 (0.010)^ 9.4 13.5 0.42 (0.517)^ 
Ischemic heart 
disease 
33.7 12.3 17.11(<0.001)^ 7.5 11.5 0.48 (0.486)^ 
Complications 
(%) 
      
Kidney disease 18.9 7.0 8.19 (0.004)^ 5.7 3.8 0.19 (0.663)^ 
Eye damage 22.6 24.6 0.15 (0.700)^ 39.6 40.4 0.01 (0.936)^ 
Neurological dis. 16.8 7.0 6.01 (0.015)^ 15.1 13.5 0.06 (0.811)^ 
Foot 4.7 2.6 0.82 (0.370)^ 9.4 5.8 1.53 (0.465)^ 
Periph. 
circulatory  
9.4 1.8 6.71 (0.010)^ 1.9 5.8 1.08 (0.299)^ 
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Figure 1. IT-DMSES items scores. All items indicate high level of diabetes management 
self-efficacy except for item 12 ‘follow a healthy eating pattern when I am eating out or at 
a party’. 
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Figure 2. Network of self-efficacy IT-DMSES items for type 1 (on the left) and type 2 
diabetes (on the right) and centrality indices (panel C: red line= type 1 diabetes; blue 
line= type 2 diabetes).  
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Figure 3. Network of self-efficacy IT-DMSES items for males (on the left) and females 
(on the right) in type 2 diabetes and centrality indices (blue line=females; red line=males). 
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Supplementary Figure 1. Network of self-efficacy IT-DMSES items for females (on the 
left) and males (on the right) in type 1 diabetes and centrality indices (blue line=females; 
red line=males).  
 
49 
 
SUPPLEMENTARY MATERIALS 
 
Supplementary material 1. DMSES-UK 
 
 
Self-Efficacy (or confidence) Questionnaire for people living with type 2 diabetes. 
 
Directions 
Below is a list of  activities you have to perform to manage your diabetes. Please read each one and 
then put a line [/] through the number which best describes how confident you usually are that you 
could carry out that activity. 
For example, if you are completely confident that you are able to check your blood sugar levels when 
nessessary, put a line through 10. If you feel  that most of the time you could not do it, put a line 
through 1 or 2. 
 
        I am confident that … 
 
       Cannot do  
        At all 
Maybe yes 
Maybe no 
                       Certain 
                       can do 
1 
I am able to check my blood sugar if necessary 
0 1 2 3 4 5 6 7 8 9 10 
2 
I am able to correct my blood sugar when the sugar level is too  
high  
0 1 2 3 4 5 6 7 8 9 10 
3 
I am able to correct my blood sugar when the blood sugar 
level is too low  
0 1 2 3 4 5 6 7 8 9 10 
4 
I am able to choose the correct foods 
0 1 2 3 4 5 6 7 8 9 10 
5 
I am able to keep my weight under control 
0 1   2   3   4   5   6   7   8 9  10 
6 
I am able to examine my feet for cuts 
0 1 2 3 4 5 6 7 8 9 10 
7 
I am able to adjust my eating plan when ill 
0 1 2 3 4 5 6 7 8 9 10 
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            I am confident that … 
 
8 
I am able to follow a healthy eating pattern most of the time 
0 1 2 3 4 5 6 7 8 9 10 
9 
I am able to take more exercise if the doctor advises me to 
0 1 2 3 4 5 6 7 8 9 10 
10 
When taking more exercise I am able to adjust my eating plan 
0 1 2 3 4 5 6 7 8 9 10 
11 
I am able to follow a healthy eating pattern when I am away  
from home 
0 1 2 3 4 5 6 7 8 9 10 
12 
I am able to follow a healthy eating pattern when I am eating out 
or at a party 
0 1 2 3 4 5 6 7 8 9 10 
13 
I am able to adjust my eating plan when I am feeling stressed  
or anxious 
0 1 2 3 4 5 6 7 8 9 10 
14 
I am able to take my medication as prescribed 
0 1 2 3 4 5 6 7 8 9 10 
15 
I am able to adjust my medication when I am ill 
0 1 2 3 4 5 6 7 8 9 10 
 
 
Sturt J, Hearnshaw H & Wakelin M. Validity and reliability of the DMSES UK: a measure of 
self-efficacy for type 2 diabetes self-management. Primary Health Care Research and 
Development. 2010;11:374–381. 
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Supplementary material 2. IT-DMSES 
 
Scala di valutazione dell’autoefficacia nella gestione del diabete 
IT-DMSES  
(Messina R., et al. 2018) 
Istruzioni:  
Sotto sono indicate una serie di attività da mettere in atto per gestire il diabete.  Segni con una 
X il numero che meglio descrive quanto lei ritiene di essere in grado di fare queste attività su 
una scala da 0 a 10. Per esempio, se crede di essere completamente capace di controllare la 
glicemia quando necessario, metta una X sul numero 10.   
 
Quanto ritiene di essere in grado di … 
 
Non sono 
in grado 
  Sono abbastanza 
        in grado                                      
                       Sono completamente 
       in grado                                                         
1. Misurare la sua glicemia quando necessario 
 
0 1 2 3 4 5 6 7 8 9 10 
2. Intervenire sulla sua glicemia quando è troppo alta  
          (ad esempio mangiando cibi differenti) 
 
0 1 2 3 4 5 6 7 8 9 10 
3. Intervenire sulla sua glicemia quando è troppo bassa  
          (ad esempio mangiando cibi differenti) 
 
0 1 2 3 4 5 6 7 8 9 10 
4. Scegliere gli alimenti corretti per la sua salute  
 
0 1 2 3 4 5 6 7 8 9 10 
5. Tenere sotto controllo il suo peso 
 
0 1   2   3   4   5   6   7   8  9   10 
6. Esaminare i suoi piedi  
          (ad esempio verificare la presenza di lesioni o ulcere) 
 
0 1 2 3 4 5 6 7 8 9 10 
7. Correggere la sua alimentazione quando è malato 
 
0 1 2 3 4 5 6 7 8 9 10 
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  Quanto ritiene di essere in grado di … 
 
 
Messina, R., Rucci, P., Sturt, J., Mancini, T., Fantini, M.P. Assessing self-efficacy in type 2 
diabetes management: Validation of the Italian version of the Diabetes Management Self-
Efficacy Scale (IT-DMSES). Health and Quality of Life Outcomes. 2018; 16(1):71. doi: 
10.1186/s12955-018-0901-3. 
 
Rucci, P., Messina, R.*, Ubiali, A., Rochira, A., van der Bijl, J., Mancini, T., Fantini, M.P., 
Pagotto, U. Does self-efficacy in diabetes management differ by type of diabetes and 
gender? Results from network analysis. Journal of Health Psychology. 2018; Article in 
Press. doi: 10.1177/1359105318804866. 
 
 
 
 
 
Non sono 
in grado 
Sono abbastanza 
     in grado 
                    Sono completamente 
                             in grado                                                         
8. Seguire solitamente una corretta alimentazione 
 
0 1 2 3 4 5 6 7 8 9 10 
9. Fare più esercizio fisico se il medico glielo suggerisce 
 
0 1 2 3 4 5 6 7 8 9 10 
10.  Modificare la sua alimentazione se svolge più attività fisica del solito 
 
0 1 2 3 4 5 6 7 8 9 10 
11.  Seguire un’alimentazione sana anche quando è fuori casa 
 
0 1 2 3 4 5 6 7 8 9 10 
12.  Seguire un’alimentazione sana quando mangia fuori  
           (ad esempio quando mangia al ristorante o ad una festa) 
 
0 1 2 3 4 5 6 7 8 9 10 
13.  Mantenere il piano alimentare quando si sente stressato o ansioso 
 
0 1 2 3 4 5 6 7 8 9 10 
14.  Assumere la terapia come da prescrizione medica 
 
0 1 2 3 4 5 6 7 8 9 10 
15.  Mantenere la sua terapia anche quando è malato 
 
0 1 2 3 4 5 6 7 8 9 10 
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Supplementary material 3. PAID-5 
 
 
Istruzioni: Quale dei seguenti problemi legati al diabete sono attualmente un problema per 
lei? 
 
Cerchi il numero che corrisponde alla risposta migliore per lei. Si prega di fornire una risposta 
per ogni domanda. 
 
Aree problematiche nel diabete (PAID-5) 
 
 
 
Non è un 
problema 
 
E’ un 
problema 
minore 
E’ un 
problema 
moderato 
E’ un 
problema 
abbastanza 
serio 
E’ un 
problema 
serio 
 
 
Avere paura quando 
pensa di dover vivere 
con il diabete 
 
0 
 
1 
 
2 
 
3 
 
4 
Sentirsi depresso 
quando pensa di 
dover vivere con il 
diabete 
0 1 2 3 4 
Essere preoccupato 
per il futuro e per la 
presenza di 
complicanze serie 
0 1 2 3 4 
Sentire che il diabete 
assorbe ogni giorno 
troppe energie 
mentali e fisiche 
0 1 2 3 4 
Far fronte alle 
complicanze del 
diabete 
0 
 
1 
 
2 
 
3 4 
 
 
Nicolucci A, Rossi MC, Pellegrini F, et al. Benchmarking network for clinical and humanistic 
outcomes in diabetes (BENCHD) study: protocol, tools, and population. SpringerPlus. 2014; 
3:1-9. 
54 
 
SUPPLEMENTARY MATERIALS  
 
Supplementary material 4. WHO-5 
 
Istruzioni: Nelle ultime due settimane come si è sentito? 
 
Cerchi il numero che corrisponde alla risposta migliore per lei. Si prega di fornire una risposta 
per ogni domanda. 
 
Indice di benessere (WHO-5)  
 
Nelle ultime due 
settimane 
 
Sempre 
 
La 
maggior 
parte del 
tempo 
Più della 
metà del 
tempo 
Meno 
della 
metà del 
tempo 
A volte 
 
Mai 
 
Mi sono sentito allegro 
e di buon umore 
5 4 3 2 1 0 
Mi sono sentito calmo 
e rilassato 
5 4 3 2 1 0 
Mi sono sentito attivo 
ed energico 
5 4 3 2 1 0 
Mi sono svegliato 
sentendomi fresco e 
riposato 
5 4 3 2 1 0 
La mia vita di tutti i 
giorni è stata piena di 
cose che mi 
interessano 
5 
 
4 
 
3 
 
2 1 0 
 
 
Bech P, Gudex C, Johansen KS. The WHO (Ten) Well-Being Index: validation in diabetes. 
Psychother Psychosom. 1996; 65:183–90. 
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Supplementary material 5. PHQ-9 
 
 
 
 
Mazzotti E, Fassone G, Pasquini P. The patient health questionnaire (PHQ) for the screening 
of psychiatric disorders: a validation study versus the structured clinical interview for DSM-
IV axis I (SCID-I). Ital J Psychopathol. 2003; 9:235–42. 
 
 
